Lasa Supergenerics Ltd Net Profit is INR 6.56 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Lasa Supergenerics Ltd Quarter Net Profit is Up by 154 % from Last Year Quarter and Net Profit of INR 6.56 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 2.58 crores.
Quarterly Net Sales Year-on-Year
Lasa Supergenerics Ltd Quarter Sale is up 37 % from Last Quarter. Sales of 53.99 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 39.29
Annual Sales & Net Earning
Lasa Supergenerics Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 169.54 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR -12.03 crores.
Lasa Supergenerics Ltd Stock Information
| Sector | Pharmaceuticals |
| Industry | Pharmaceuticals – Indian – Bulk Drugs & Formln |
| About | Lasa Supergenerics Limited is an India-based company engaged in the manufacturing of anthelmintics/veterinary active pharmaceutical ingredient (API). |
| Latest Qaurter EPS | 1.6128693667997716 |
Lasa Supergenerics Ltd Stock Analysis:
Get more Quarterly Earnings Results of companies
Get complete data on Lasa Supergenerics Ltd
